Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 3"
topic_facet:"Diabetes Mellitus, Type 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (1.146)
1
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease : Effect of Semaglutide Versus Placebo on the Progression of Renal Impairment in Subjects With Type 2 Diabetes and Chronic Kidney Disease
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes : Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) : A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Semaglutide Once Weekly in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes : The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor : Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. in Doses 2.4/2.4 mg and 1.0/1.0 mg Once Weekly Versus Semaglutide 2.4 mg and 1.0 mg, Cagrilintide 2.4 mg and Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Metformin With or Without an SGLT2 Inhibitor
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes : A Study to Evaluate the Efficacy and Safety of Once-weekly Insulin Icodec When Switching From Daily Basal Insulins Compared to Once-daily Insulin Glargine U100 in Adults With Type 2 Diabetes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight : Effect and Safety of Semaglutide 7.2 mg Once-weekly in Participants With Obesity and Type 2 Diabetes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor : Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) 2.4 mg/2.4 mg s.c. Once Weekly Versus Tirzepatide 15 mg s.c. Once Weekly in Participants With Type 2 Diabetes Inadequately Controlled on Metformin With or Without an SGLT2 Inhibitor
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight : Efficacy and Safety of Cagrilintide s.c. 2.4 mg in Combination With Semaglutide s.c. 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity and Type 2 Diabetes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin : Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. in Doses 2.4 mg/2.4 mg and 1.0 mg/1.0 mg Once Weekly Versus Placebo in Participants With Type 2 Diabetes as Add on to Once-daily Basal Insulin With or Without Metformin
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[115]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 3
Filter aufheben
Thema: Diabetes Mellitus, Type 2
Medienart
1.146
Aufsätze
1.146
E-Artikel
1.146
E-Ressourcen
Zeitschriftentitel
1.146
ClinicalTrials.gov
Thema
1.146
610
Diabetes Mellitus, Type 2
Phase: Phase 3
1.146
Study Type: Interventional
969
Diabetes Mellitus
830
Recruitment Status: Completed
253
Medical Condition: Type 2 Diabetes Mellitus
197
Medical Condition: Diabetes Mellitus, Type 2
120
Medical Condition: Type 2 Diabetes
118
Medical Condition: Diabetes, Diabetes Mellitus,...
103
Recruitment Status: Terminated
81
Recruitment Status: Recruiting
45
Recruitment Status: Active, not recruiting
31
Recruitment Status: Not yet recruiting
30
Kidney Diseases
30
Medical Condition: Diabetes Mellitus Type 2
29
Recruitment Status: Unknown status
22
Renal Insufficiency, Chronic
21
Diabetes Mellitus, Type 1
21
Obesity
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
398
2020-
683
2010-2019
65
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.146
Englisch
Haven't found what you're looking for?
Wird geladen...